LoadingLoadingLoading34 funds hold it.Insiders net selling.
Net selling: insiders sold $20.4M and bought $62K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 22, 2026
Period ending
Sep 30, 2026
Earnings per share
$1.26 expected
Revenue
Financial statements: Alpha Vantage
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 22, 2026 | $1.32est. $1.26 | +4.88%beat | $3.06BAlpha Vantage | -0.8%from $3.09B |
| Jun 30, 2026Reported Jul 23, 2026 | $1.52est. $1.34 | +13.71%beat | $5.04BSEC filing | +35.9%from $3.71B |
| Mar 31, 2026Reported Apr 23, 2026 | $1.36est. $1.34 | +1.69%beat | $3.62BSEC filing | +10.0%from $3.29B |
| Dec 31, 2025Reported Jan 29, 2026 | $1.75est. $1.54 | +13.92%beat | $4.36BAlpha Vantage | +54.7%from $2.82B |
| Sep 30, 2025Reported Oct 23, 2025 | $1.52est. $1.23 | +23.58%beat | $3.09BSEC filing | -15.7%from $3.66B |
| Jun 30, 2025Reported Jul 24, 2025 | $1.21est. $1.10 | +10.00%beat | $3.71BSEC filing | +32.7%from $2.80B |
| Mar 31, 2025Reported Apr 17, 2025 | $1.09est. $1.06 | +2.83%beat | $3.29BSEC filing | -10.8%from $3.69B |
| Dec 31, 2024Reported Jan 30, 2025 | $1.69est. $1.47 | +14.97%beat | $2.82BAlpha Vantage | +132.0%from $1.21B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.36B | $4.10B | $4.77B | $3.06B |
| Cost of what it sold | $1.55B | $60.3M | $58.9M | $9.7M |
| Gross profit | $2.81B | $4.04B | $4.71B | $3.05B |
| What it spent | ||||
| Sales and admin | $447.8M | $380.8M | $1.37B | $1.48B |
| Other operating costs | — | $2.07B | $384.7M | — |
| Total operating expenses | $447.8M | $2.45B | $1.76B | $1.48B |
| What was left | ||||
| Operating profit | $2.36B | $1.59B | $2.95B | $1.57B |
| Interest on debt | $128.1M | $137.1M | $145.0M | $132.9M |
| Profit before tax | $2.36B | $1.46B | $2.81B | $1.53B |
| Tax | $382.0M | $197.2M | $452.4M | $258.6M |
| Net profit | $1.02B | $649.7M | $1.23B | $662.4M |
| EBITDA | $2.37B | $1.60B | $2.96B | $1.69B |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
If you saw dancers dangling from a Kendall Square building last night, don’t be alarmed
Leans bullishNov 6PPL Targets Up to 9% EPS Growth With $25 Billion Investment Plan
NeutralNov 6Blackstone, Aon Set Up Lloyd’s Vehicle in Latest Insurance Push
NeutralNov 6Maverick's Vik Uppal Went a Year Without a Deal. He Says That's the Edge.
Leans bullishNov 6Why You Might Be Interested In Ameriprise Financial, Inc. (NYSE:AMP) For Its Upcoming Dividend
NeutralNov 6Blackstone funds, Aon team up to launch new Lloyd's syndicate for reinsurance (BX:NYSE)
BullishNov 6Editas Medicine (NASDAQ:EDIT) Stock Breaks Below Two Hundred Day Moving Average - Time to Sell?
Leans bullishNov 6Blackstone Life Sciences, Boston Scientific to co-fund development of miniature heart pump
BullishNov 6
